PLCD1 and breast cancer: The cellular effects of the thieno[2,3-b]pyridine derivative 3 are comparable to those observed in MDA-MB-231 breast cancer cells following PLC–δ1 and –δ3 gene knockdown [8], which induces severe growth inhibition and G2-phase cell cycle arrest.